Filippo Petti Celyad's guest appearances

Filippo Petti Celyad

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Filippo Petti, CEO, Celyad discusses how the company is broadening precision medicine by developing CAR-T immunotherapies to express a natural killer receptor that can recognize and target multiple ligands expressed in up to 80% of all cancers.  Filippo talks about the value to cancer patients of both personalized (autologous) and off the shelf (allogeneic) CAR-T therapies and CYAD-101, Celyad's allogeneic CAR-T therapy, that demonstrated for the first time ever, clinical effectiveness in solid tumors. @CelyadSA #CAR_T #NKCells #cancer #immunotherapy #CellTherapy #solidtumors #Tcell #CYAD101 #allogeneic $CYAD Celyad.com Download the transcript here

Filippo Petti, CEO, Celyad discusses how the company is broadening precision medicine by developing CAR-T immunotherapies to express a natural killer receptor that can recognize and target multiple ligands expressed in up to 80% of all cancers.  Filippo talks about the value to cancer patients of both personalized (autologous) and off the shelf (allogeneic) CAR-T therapies and CYAD-101, Celyad's allogeneic CAR-T therapy, that demonstrated for the first time ever, clinical effectiveness in solid tumors. @CelyadSA #CAR_T #NKCells #cancer #immunotherapy #CellTherapy #solidtumors #Tcell #CYAD101 #allogeneic $CYAD <a href="http://celyad.com" rel="noopener nofollow" target="_blank">Celyad.com</a> <a href="http://empoweredpatientradio.com/allogeneic-car-t-immunotherapies-showing-promise-for-solid-tumors-with-filippo-petti-celyad-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Allogeneic CAR-T Immunotherapies Showing Promise for Solid Tumors with Filippo Petti Celyad